Verification of a previously obtained EQA based MUC1/CA15-3 harmonisation procedure
Tumor Biology · 2026-11 · 48
DOI: 10.1177/14230380261504697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tumor Biology, online erschienen am 04.11.2026. Verfasst von Huub H van Rossum und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Mucin-1, Breast Neoplasms, Biomarkers, Tumor, Antigens, Tumor-Associated, Carbohydrate. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
MUC1/CA 15-3 is the most widely used circulating marker for monitoring treatment in patients with advanced breast cancer. Previous studies demonstrated that MUC1/CA 15-3 tests are insufficiently harmonised and an EQA-based harmonisation procedure has been developed. This study aims to validate the obtained MUC1/CA 15-3 harmonisation procedure and to explore the suitability of MUC1/CA 15-3 materials as a base for developing future MUC1/CA 15-3 reference materials.
Methods
Sera from 45 patients were obtained and five additional samples were prepared from commercial MUC1/CA 15-3 materials. All samples were analyzed by measurement procedures of Abbott Alinity, Beckman DxI, Roche Cobas and Siemens Atellica. Data analysis included application of the previously obtained MUC1/CA 15-3 harmonisation procedure that required recalibration of Beckman DxI only, pre-and post-harmonisation Passing-Bablok regression, Spearman correlation coefficient and Bland-Altman difference analyses. Suitability of the MUC1/CA 15-3 materials as basis of future standards was also investigated.
Results
The slopes obtained from the regression analysis of individual MUC1/CA15-3 assays ranged from 0.598 to 1.96 pre-harmonisation and 0.8448 to 1.150 post-harmonisation. The mean difference of individual measurement procedures with the consensus mean improved from −26.65% to 22.83% before harmonisation to −12.78% to 10.95% after harmonisation. The difference between the MUC1/CA 15-3 spiked materials and the patient sample mean differences were ≤10,1% and fell within the 95% limits of agreement.
Conclusions
The EQA-based mathematical harmonisation procedure for MUC1/CA 15-3 resulted in improved MUC1/CA 15-3 harmonisation with real-world clinical samples. The MUC1/CA 15-3 materials provided a suitable base for further exploration as reference materials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Klinisch Chemisch Laboratorium, Rode Kruis Ziekenhuis, Beverwijk, The Netherlands.
- Central Diagnostic Laboratory, University Medical Centre Utrecht, Utrecht, The Netherlands.
- Department of Laboratory Medicine, Meander Medical Centre, Amersfoort, The Netherlands.
- UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
- Clinical Research Centre, St Vincent's Hospital, Dublin, Ireland.
ORCID-Profile: Huub H van Rossum, Theodora C Linders, Michael J Duffy, Melanie Moore
Zitieren
APA
van Rossum, H. H., Linders, T. C., Huijgen, H., Musson, R. E. A., Demir, A. Y., Duffy, M. J., & Moore, M. (2026). Verification of a previously obtained EQA based MUC1/CA15-3 harmonisation procedure. Tumor Biology, 48. https://doi.org/10.1177/14230380261504697
Vancouver
van Rossum HH, Linders TC, Huijgen H, Musson REA, Demir AY, Duffy MJ, et al. Verification of a previously obtained EQA based MUC1/CA15-3 harmonisation procedure. Tumor Biology. 2026;48. doi:10.1177/14230380261504697
BibTeX
@article{vanRossum2026,
author = {van Rossum, Huub H and Linders, Theodora C and Huijgen, Henk and Musson, Ruben E A and Demir, Ayşe Y and Duffy, Michael J and Moore, Melanie},
title = {Verification of a previously obtained EQA based MUC1/CA15-3 harmonisation procedure},
journal = {Tumor Biology},
year = {2026},
volume = {48},
doi = {10.1177/14230380261504697}
}
EUVIMED